| point be | 0.33 | One case critics point to are the patent rights awarded to Human Genome Sciences. | ||
| point lower | 0.33 | One indicator pointed to lower share prices when trading opens. | ||
| point score | 0.33 | - to score the pivotal points. |
| point be | 0.33 | One case critics point to are the patent rights awarded to Human Genome Sciences. | ||
| point lower | 0.33 | One indicator pointed to lower share prices when trading opens. | ||
| point score | 0.33 | - to score the pivotal points. |